Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 61

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma

Turnham, Rigney E, Smith, F Donelson, Kenerson, Heidi L, Omar, Mitchell H, Golkowski, Martin, Garcia, Irvin, Bauer, Renay, Lau, Ho-Tak, Sullivan, Kevin M, Langeberg, Lorene K, Ong, Shao-En, Riehle, Kimberly J, Yeung, Raymond S, Scott, John D · 2019 · eLife

Abstract

Fibrolamellar carcinoma (FLC) is a rare liver cancer. FLCs uniquely produce DNAJ-PKAc, a chimeric enzyme consisting of a chaperonin-binding domain fused to the Cα subunit of protein kinase A. Biochemical analyses of clinical samples reveal that a unique property of this fusion enzyme is the ability to recruit heat shock protein 70 (Hsp70). This cellular chaperonin is frequently up-regulated in cancers. Gene-editing of mouse hepatocytes generated disease-relevant AML12DNAJ-PKAc cell lines. Further analyses indicate that the proto-oncogene A-kinase anchoring protein-Lbc is up-regulated in FLC and functions to cluster DNAJ-PKAc/Hsp70 sub-complexes with a RAF-MEK-ERK kinase module. Drug screening reveals Hsp70 and MEK inhibitor combinations that selectively block proliferation of AML12DNAJ-PKAc cells. Phosphoproteomic profiling demonstrates that DNAJ-PKAc biases the signaling landscape toward ERK activation and engages downstream kinase cascades. Thus, the oncogenic action of DNAJ-PKAc involves an acquired scaffolding function that permits recruitment of Hsp70 and mobilization of local ERK signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.44187

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 70

  1. Aggarwal, 2019, Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility, Journal of Biological Chemistry, 294, 3152, 10.1074/jbc.RA118.006741 · DOI
  2. Ang, 2013, Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium, Gastrointestinal Cancer Research : GCR, 6, 3
  3. Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal cushing's syndrome, New England Journal of Medicine, 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
  4. Burgers, 2012, A small novel A-kinase anchoring protein (AKAP) that localizes specifically protein kinase A-regulatory subunit I (PKA-RI) to the plasma membrane, Journal of Biological Chemistry, 287, 43789, 10.1074/jbc.M112.395970 · DOI
  5. Calderwood, 2006, Heat shock proteins in cancer: chaperones of tumorigenesis, Trends in Biochemical Sciences, 31, 164, 10.1016/j.tibs.2006.01.006 · DOI · Paper page
  6. Cao, 2019, Structures of the PKA riα holoenzyme with the FLHCC driver J-PKAcα or Wild-Type PKAcα, Structure, 27, 816, 10.1016/j.str.2019.03.001 · DOI · Paper page
  7. Carr, 1992, Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII-binding domain, Journal of Biological Chemistry, 5, 13376, 10.1016/S0021-9258(18)42221-1 · DOI · Paper page
  8. Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, PNAS, 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
  9. Cho, 2000, Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking calpha and RIIbeta subunit overexpression, PNAS, 97, 835, 10.1073/pnas.97.2.835 · DOI
  10. Cho-Chung, 2005, Tumor reversion: protein kinase A isozyme switching, Annals of the New York Academy of Sciences, 1058, 76, 10.1196/annals.1359.014 · DOI
  11. Cornella, 2015, Unique genomic profile of fibrolamellar hepatocellular carcinoma, Gastroenterology, 148, 806, 10.1053/j.gastro.2014.12.028 · DOI
  12. Craig, 1980, Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features, Cancer, 46, 372, 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S · doi:10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s
  13. Cvijic, 2000, Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 6, 2309
  14. Dalby, 1998, Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK, Journal of Biological Chemistry, 273, 1496, 10.1074/jbc.273.3.1496 · DOI · Paper page
  15. Dinh, 2017, Comprehensive analysis of the cancer genome atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma, Scientific Reports, 7, 10.1038/srep44653 · DOI
  16. Diviani, 2001, AKAP-Lbc anchors protein kinase A and nucleates galpha 12-selective Rho-mediated stress fiber formation, The Journal of Biological Chemistry, 276, 44247, 10.1074/jbc.M106629200 · DOI · Paper page
  17. Dumaz, 2005, Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie lecture delivered on 5 July 2003 at the special FEBS meeting in Brussels, FEBS Journal, 272, 3491, 10.1111/j.1742-4658.2005.04763.x · DOI · Paper page
  18. Engelholm, 2017, CRISPR/Cas9 engineering of adult mouse liver demonstrates That the Dnajb1 – Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma, Gastroenterology, 153, 1662, 10.1053/j.gastro.2017.09.008 · DOI
  19. Eugênio, 2017, Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma, Oncotarget, 8, 114698, 10.18632/oncotarget.22815 · DOI
  20. Feramisco, 1980, Optimal spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase, The Journal of Biological Chemistry, 255, 4240, 10.1016/S0021-9258(19)85658-2 · DOI · Paper page
  21. Ficarro, 2009, Magnetic bead processor for rapid evaluation and optimization of parameters for phosphopeptide enrichment, Analytical Chemistry, 81, 4566, 10.1021/ac9004452 · doi:10.1021/ac9004452
  22. Golkowski, 2016, Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in leydig cell function with phosphoproteomics, Cellular Signalling, 28, 764, 10.1016/j.cellsig.2015.11.014 · DOI
  23. Golkowski, 2017, Kinobead and Single-Shot LC-MS profiling identifies selective PKD inhibitors, Journal of Proteome Research, 16, 1216, 10.1021/acs.jproteome.6b00817 · DOI
  24. Goloudina, 2012, Inhibition of HSP70: a challenging anti-cancer strategy, Cancer Letters, 325, 117, 10.1016/j.canlet.2012.06.003 · DOI · Paper page
  25. Graham, 2018, Fibrolamellar carcinoma in the Carney complex: prkar1a loss instead of the classic DNAJB1-PRKACA fusion, Hepatology, 68, 1441, 10.1002/hep.29719 · DOI · Paper page
  26. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  27. Hennessy, 2005, Not all J domains are created equal: implications for the specificity of Hsp40-Hsp70 interactions, Protein Science, 14, 1697, 10.1110/ps.051406805 · DOI · Paper page
  28. Hogrebe, 2018, Benchmarking common quantification strategies for large-scale phosphoproteomics, Nature Communications, 9, 10.1038/s41467-018-03309-6 · DOI · Paper page
  29. Honeyman, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
  30. Horn, 2014, KinomeXplorer: an integrated platform for kinome biology studies, Nature Methods, 11, 603, 10.1038/nmeth.2968 · DOI · Paper page
  31. Kastenhuber, 2017, DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma, PNAS, 114, 13076, 10.1073/pnas.1716483114 · DOI · Paper page
  32. Kastenhuber, 2019, Road map for fibrolamellar carcinoma: progress and goals of a diversified approach, Journal of Hepatocellular Carcinoma, 6, 41, 10.2147/JHC.S194764 · DOI
  33. Kolch, 2015, The dynamic control of signal transduction networks in cancer cells, Nature Reviews Cancer, 15, 515, 10.1038/nrc3983 · DOI · Paper page
  34. Lacroix, 2015, Cushing's syndrome, The Lancet, 386, 913, 10.1016/S0140-6736(14)61375-1 · DOI · Paper page
  35. Lalazar, 2018, Fibrolamellar carcinoma: recent advances and unresolved questions on the molecular mechanisms, Seminars in Liver Disease, 38, 051, 10.1055/s-0037-1621710 · DOI · Paper page
  36. Langeberg, 2015, Signalling scaffolds and local organization of cellular behaviour, Nature Reviews Molecular Cell Biology, 16, 232, 10.1038/nrm3966 · DOI · Paper page
  37. Liu, 2018, The significance of intertumor and intratumor heterogeneity in liver cancer, Experimental & Molecular Medicine, 50, 10.1038/emm.2017.165 · DOI · Paper page
  38. Macario, 2007, Chaperonopathies by defect, excess, or mistake, Annals of the New York Academy of Sciences, 1113, 178, 10.1196/annals.1391.009 · DOI
  39. Mayer, 2005, Hsp70 chaperones: cellular functions and molecular mechanism, Cellular and Molecular Life Sciences, 62, 670, 10.1007/s00018-004-4464-6 · DOI · Paper page
  40. McCartney, 1995, Cloning and characterization of A-kinase anchor protein 100 (AKAP100), Journal of Biological Chemistry, 270, 9327, 10.1074/jbc.270.16.9327 · DOI
  41. Means, 2011, An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria, PNAS, 108, E1227, 10.1073/pnas.1107182108 · DOI
  42. Oikawa, 2015, Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells, Nature Communications, 6, 10.1038/ncomms9070 · DOI
  43. Olsen, 2010, Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis, Science Signaling, 3, 10.1126/scisignal.2000475 · DOI · Paper page
  44. Pauli, 2017, Personalized in vitro and In Vivo Cancer Models to Guide Precision Medicine, Cancer Discovery, 7, 462, 10.1158/2159-8290.CD-16-1154 · DOI · Paper page
  45. Porter, 2001, Regulation of lung epithelial cell morphology by cAMP-dependent protein kinase type I isozyme, American Journal of Physiology-Lung Cellular and Molecular Physiology, 280, L1282, 10.1152/ajplung.2001.280.6.L1282 · DOI
  46. Pribluda, 2015, Intratumoral heterogeneity: from diversity comes resistance, Clinical Cancer Research, 21, 2916, 10.1158/1078-0432.CCR-14-1213 · DOI
  47. Ran, 2013, Genome engineering using the CRISPR-Cas9 system, Nature Protocols, 8, 2281, 10.1038/nprot.2013.143 · DOI · Paper page
  48. Rhayem, 2015, Functional characterization of PRKAR1A mutations reveals a unique molecular mechanism causing acrodysostosis but multiple mechanisms causing Carney complex, Journal of Biological Chemistry, 290, 27816, 10.1074/jbc.M115.656553 · DOI
  49. Riggle, 2016, Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma, Pediatric Research, 80, 110, 10.1038/pr.2016.36 · DOI · Paper page
  50. Riggle, 2016, Fibrolamellar hepatocellular carcinoma: Mechanistic distinction from adult hepatocellular carcinoma, Pediatric Blood & Cancer, 63, 1163, 10.1002/pbc.25970 · DOI · Paper page
  51. Rossomando, 1992, Identification of Tyr-185 as the site of tyrosine autophosphorylation of recombinant mitogen-activated protein kinase p42mapk, PNAS, 89, 5779, 10.1073/pnas.89.13.5779 · DOI
  52. Sato, 2014, Recurrent somatic mutations underlie corticotropin-independent cushing's syndrome, Science, 344, 917, 10.1126/science.1252328 · DOI · Paper page
  53. Scott, 1985, Amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase from rabbit skeletal muscle, PNAS, 82, 5732, 10.1073/pnas.82.17.5732 · DOI · Paper page
  54. Scott, 2009, Cell signaling in space and time: where proteins come together and when they're apart, Science, 326, 1220, 10.1126/science.1175668 · DOI · Paper page
  55. Simon, 2015, Transcriptomic characterization of fibrolamellar hepatocellular carcinoma, PNAS, 112, E5916, 10.1073/pnas.1424894112 · DOI · Paper page
  56. Smith, 2010, AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade, Nature Cell Biology, 12, 1242, 10.1038/ncb2130 · DOI
  57. Smith, 2017, Local protein kinase A action proceeds through intact holoenzymes, Science, 356, 1288, 10.1126/science.aaj1669 · DOI · Paper page
  58. Smith, 2018, Single nucleotide polymorphisms alter kinase anchoring and the subcellular targeting of A-kinase anchoring proteins, PNAS, 115, E11465, 10.1073/pnas.1816614115 · DOI
  59. Stewart, 1999, Kinase suppressor of ras forms a multiprotein signaling complex and modulates MEK localization, Molecular and Cellular Biology, 19, 5523, 10.1128/MCB.19.8.5523 · DOI · Paper page
  60. Stratakis, 2013, cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse, Molecular and Cellular Endocrinology, 371, 208, 10.1016/j.mce.2013.01.015 · DOI
  61. Takahashi, 2017, Phosphorylation of Rap1 by cAMP-dependent protein kinase (PKA) Creates a binding site for KSR to sustain ERK activation by cAMP, Journal of Biological Chemistry, 292, 1449, 10.1074/jbc.M116.768986 · DOI
  62. Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nature Reviews Molecular Cell Biology, 13, 646, 10.1038/nrm3432 · DOI · Paper page
  63. Toyoshima, 2012, Functional genomics identifies therapeutic targets for MYC-driven cancer, PNAS, 109, 9545, 10.1073/pnas.1121119109 · DOI · Paper page
  64. Turnham, 2016, Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology, Gene, 577, 101, 10.1016/j.gene.2015.11.052 · DOI · Paper page
  65. Tyanova, 2016, The perseus computational platform for comprehensive analysis of (prote)omics data, Nature Methods, 13, 731, 10.1038/nmeth.3901 · DOI · Paper page
  66. Villén, 2008, The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry, Nature Protocols, 3, 1630, 10.1038/nprot.2008.150 · DOI · Paper page
  67. Wen, 2014, VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines, Experimental Biology and Medicine, 239, 638, 10.1177/1535370214527899 · DOI
  68. Whiting, 2015, Protein kinase A opposes the Phosphorylation-dependent recruitment of glycogen synthase kinase 3β to A-kinase anchoring protein 220, Journal of Biological Chemistry, 290, 19445, 10.1074/jbc.M115.654822 · DOI
  69. Wu, 1994, Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha, PNAS, 91, 674, 10.1073/pnas.91.2.674 · DOI · Paper page
  70. Xu, 2015, Genomic analysis of fibrolamellar hepatocellular carcinoma, Human Molecular Genetics, 24, 50, 10.1093/hmg/ddu418 · DOI · Paper page

Cited by

See all 61

Metadata

Authors
Turnham, R. E., Smith, F. D., Kenerson, H. L., Omar, M. H., Golkowski, M., Garcia, I., Bauer, R., Lau, H.-T., Sullivan, K. M., Langeberg, L. K., Ong, S.-E., Riehle, K. J., Yeung, R. S., & Scott, J. D.
Venue
eLife
Published
2019-05-07
Volume
8
ISSN
2050-084X
Cited by
61
References
5
Language
en
Funders
  • National Institutes of Health (2T32CA080416)
  • National Institute of Diabetes and Digestive and Kidney Diseases (F32DK121415, R01DK119192)
  • National Cancer Institute (R21CA177402, R21CA201867)
  • NIH Office of the Director (S10 OD021502)
  • St. Baldrick's Foundation (Research Award)
  • Fibrolamellar Cancer Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma. https://app.cochat.ai/papers/10.7554/elife.44187
The paper
Turnham, R. E., Smith, F. D., Kenerson, H. L., Omar, M. H., Golkowski, M., Garcia, I., Bauer, R., Lau, H.-T., Sullivan, K. M., Langeberg, L. K., Ong, S.-E., Riehle, K. J., Yeung, R. S., & Scott, J. D. (2019). An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma. eLife. https://doi.org/10.7554/elife.44187

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.